Becton, Dickinson and Co.
$181.38
-$0.47 (-0.26%)
$181.27Day Range$184.34
Key Statistics
Market Cap
$49.41B
Shares Outstanding
272.4M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Sep 25, 1963
Round Lot
100
Locale
US
Trading Data
Day Open
$182.71
Day High
$184.34
Day Low
$181.27
Volume
1.84M
VWAP
$182.36
Prev Close
$181.85
Transactions
--
Acc. Volume
--
About Becton, Dickinson and Co.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384172,000 employeesONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880(201) 847-6800IPO Sep 25, 1963US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000010795
- Composite FIGI
- BBG000BCZYD3
- Share Class FIGI
- BBG001S5P374
- Ticker Root
- BDX
- SIC Code
- 3841
About Becton, Dickinson and Co. (BDX) Stock
Becton, Dickinson and Co. (BDX) closed the 2026-09-17 session at $181.38, down 0.26% versus the previous close (-0.47). The stock opened at $182.71 and traded between $181.27 and $184.34 during that session. Session trading volume was 1.8M shares. The volume-weighted average price (VWAP) is $182.36.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Becton, Dickinson and Co. has a market capitalization of $49.41 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. BDX is listed on the XNYS exchange. The company employs approximately 72,000 people. Becton, Dickinson and Co. is headquartered in FRANKLIN LAKES, NJ. The recorded listing date is 1963-09-25.
On this page you can find market BDX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.